Previous Article | Next Article ![]()
Applied and Environmental Microbiology, June 2001, p. 2657-2664, Vol. 67, No. 6
Pharmaceutical Cosmetic Raw Materials and
Natural Products Research and Development Center, Institute for Science
and Technology Research and Development,1 and
Department of Pharmaceutical Technology, Faculty of
Pharmacy,2 and Department of Clinical
Immunology, Faculty of Associated Medical
Sciences,3 Chiang Mai University, 50200 Chiang Mai, Thailand, and Microbielle Genetik,
Universität Tübingen, D-72076
Tübingen,4 and Boehringer
Ingelheim Pharma KG, 88397 Biberach (Riss),5
Germany
Received 6 November 2000/Accepted 20 March 2001
The DNA fragment coding for kringle 2 plus serine protease
domains (K2S) of tissue plasminogen activator (tPA) was
inserted into a phagemid vector, pComb3HSS. In the recombinant vector, pComb3H-K2S, the K2S gene was fused to
gpIII of
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.6.2657-2664.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Secretion of Active Recombinant Human Tissue
Plasminogen Activator Derivatives in Escherichia
coli
M13 and linked to the OmpA signal sequence.
The resulting gene, rK2S-gpIII, was inducibly expressed
in Escherichia coli XL-1 Blue. The protein was presented
on the phage particle. To stop the expression of gpIII,
a stop codon between K2S and the gpIII
gene was inserted by site-directed mutagenesis. This mutated vector,
MpComb3H-K2S, was transformed in XL-1 Blue. After
induction with IPTG
(isopropyl-
-D-thiogalactopyranoside), rK2S was found
both in the periplasm as an inactive form of approximately 32% and in
the culture supernatant as an active form of approximately 68%.
The secreted form of rK2S was partially purified by ammonium sulfate
(55%) precipitation. The periplasmic form was isolated from whole
cells by chloroform extraction. The fibrin binding site of kringle 2 was demonstrated in all expressed versions (phage-bound, periplasmic,
and secreted forms) using the monoclonal anti-kringle 2 antibody
(16/B). Only the secreted form of rK2S revealed a fibrinogen-dependent amidolytic activity with the specific activity of 236 IU/µg. No amidolytic activity of rK2S was observed in either the periplasmic or
the phage-bound form. The secretion of rK2S as an active enzyme offers
a novel approach for the production of the active-domain deletion
mutant tPA, rK2S, without any requirements for bacterial compartment
preparation and in vitro refolding processes. This finding is an
important technological advance in the development of large-scale,
bacterium-based tPA production systems.
*
Corresponding author. Mailing address: Department of
Pharmaceutical Technology, Faculty of Pharmacy, Chiang Mai University, 50200 Chiang Mai, Thailand. Phone: 66-53-894806 or 66-53-944338. Fax:
66-53-894169. E-mail: pmpti006{at}chiangmai.ac.th.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»